NovaBay Pharmaceuticals (NYSE:NBY) Shares Up 1.4%

NovaBay Pharmaceuticals, Inc. (NYSE:NBY) shares traded up 1.4% on Wednesday . The company traded as high as $2.25 and last traded at $2.16. 135,401 shares were traded during trading, a decline of 30% from the average session volume of 192,822 shares. The stock had previously closed at $2.13.

Wall Street Analyst Weigh In

Separately, StockNews.com assumed coverage on shares of NovaBay Pharmaceuticals in a research report on Monday, June 10th. They set a “hold” rating on the stock.

NovaBay Pharmaceuticals Stock Down 63.1 %

The firm has a market cap of $965,115.00, a P/E ratio of -0.01 and a beta of 0.83. The firm’s 50-day simple moving average is $2.79 and its 200 day simple moving average is $3.88.

NovaBay Pharmaceuticals (NYSE:NBY) last announced its quarterly earnings data on Thursday, May 9th. The company reported ($4.90) EPS for the quarter. The company had revenue of $2.63 million during the quarter. NovaBay Pharmaceuticals had a negative return on equity of 304.39% and a negative net margin of 80.76%. As a group, analysts forecast that NovaBay Pharmaceuticals, Inc. will post -5.24 earnings per share for the current year.

Hedge Funds Weigh In On NovaBay Pharmaceuticals

An institutional investor recently bought a new position in NovaBay Pharmaceuticals stock. Armistice Capital LLC bought a new position in NovaBay Pharmaceuticals, Inc. (NYSE:NBY) in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm bought 718,768 shares of the company’s stock, valued at approximately $147,000. Armistice Capital LLC owned approximately 11.01% of NovaBay Pharmaceuticals as of its most recent SEC filing. Institutional investors own 23.25% of the company’s stock.

About NovaBay Pharmaceuticals

NovaBay Pharmaceuticals, Inc, a biopharmaceutical company, develops and sells eyecare, skincare, and wound care products in the United States and internationally. It offers Avenova Spray, a solution for removing foreign materials, including microorganisms and debris from skin around the eye, such as the eyelid; and wound care products, which are used for cleansing and irrigation as part of surgical procedures, as well as treating certain wounds, burns, ulcers, and other injuries under the NeutroPhase and PhaseOne brands.